| Dr Bernard Provencher, PHARMD | |
|
1 Granite Pl Ste 200, Concord, NH 03301-3271 | |
| (603) 226-8686 | |
| Not Available |
| Full Name | Dr Bernard Provencher |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1 Granite Pl Ste 200, Concord, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760798748 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P1200X | Pharmacist - Pharmacotherapy | 3524 (New Hampshire) | Secondary |
| 183500000X | Pharmacist | 3524 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bernard Provencher, PHARMD 1 Granite Pl Ste 200, Concord, NH 03301-3271 Ph: (603) 226-8686 | Dr Bernard Provencher, PHARMD 1 Granite Pl Ste 200, Concord, NH 03301-3271 Ph: (603) 226-8686 |
News Archive
Two of Almac's main research projects have been selected for presentation at the 2011 ASCO meeting. Both of these studies are based on Almac's approach of profiling large clinical datasets and analysing the data for molecular subgroups that can aid in improved diagnosis of cancer by identifying molecular subtypes and by identifying molecular subgroups which are of clinical and therapeutic relevance.
A new study has revealed key steps for hospitals to improve care for pregnant mums and babies affected by a life-threatening condition.
Reports reveal that Midland hospitals have won the war against the killer superbug Methicillin-resistant Staphylococcus aureus (MRSA) and some NHS trusts have completely eradicated the disease. The infection was hitting more than a thousand vulnerable patients in the region every year at its peak in 2004 and 2005, leading to many deaths.
BioLight Life Sciences Investments, a company focused primarily on the discovery, development and commercialization of breakthrough ophthalmic diagnostics and therapeutics, announced today that it has entered into a joint financing agreement (the "Agreement") with two Asia-based venture capital firms (the "New Investors"), pursuant to which BioLight and the New Investors will make a direct equity investment in BioLight's IOPtima Ltd. subsidiary via a private placement.
› Verified 6 days ago
Mr. Richard Jon Tripp, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 250 Pleasant St, Concord, NH 03301 Phone: 603-225-2711 | |
Mr. John Michael Tracy Sr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 38 Locke Rd, Suite 3, Concord, NH 03301 Phone: 603-223-0380 Fax: 603-223-0347 | |
Mary Kate Langlais-mcnutt, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 92 South St, Concord, NH 03301 Phone: 603-228-8400 | |
Mr. John Christopher Wakelin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 125 N Main St, Concord, NH 03301 Phone: 603-224-9591 Fax: 603-224-5361 | |
Joseph Pirani, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Granite Pl Ste N200, Concord, NH 03301 Phone: 603-226-8686 | |
Mrs. Ann Marie Bisson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 125 N Main St, Concord, NH 03301 Phone: 603-224-9591 | |
Mr. Khiem D Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4 Hall St, Concord, NH 03103 Phone: 603-623-3532 |